ONO PHARMACEUTICAL CO., LTD.
小野薬品工業株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4528
FY2025 · 2026-03-31
| Gross margin | 72.5% |
| Operating margin | 17.9% |
| Net margin | 13.5% |
| Return on equity | 8.2% |
| Return on assets | 6.3% |
| Revenue growth (YoY) | 5.9% |
| EPS (basic) | ¥148.49 |
| EPS growth (YoY) | 39.4% |
| Current ratio | — |
| Equity ratio | 76.9% |
| Book value / share | ¥1,797.89 |
| Free cash flow | 130,797 M |